Nature biotechnology [electronic resource]., Tập 32, Số 12, 2014
Mục lục:
DòngNội dung
1Label without a cause : Mandatory labeling of GM food in the United States will not only make all food more costly but also bamboozle consumers.
2Developers seek to finetune toxicity of T-cell therapies
3Stem cell therapy clears first hurdle in AMD2-5
4Celgene wagers on Sutro’s cell-free platform to ramp up ADCs
5Who owns CRISPR-Cas9 in Europe? / András Kupecz
6Taking charge of siRNA delivery / Anastasia Khvorova, Maire F Osborn, and Matthew R Hassler
7Lightening the load in synthetic biology / Leric Klavins
8A community effort to assess and improve drug sensitivity prediction algorithms / James C Costello and others
9a community computational challenge to predict the activity of pairs of compounds / Mukesh Bansal and others
10long-term persistence and development of induced pancreatic beta cells generated by lineage conversion of acinar cells / Weida Li and others
11single-base resolution analysis of active DNA demethylation using methylase-assisted bisulfite sequencing / Hao Wu and others
12Functional optimization of gene clusters by combinatorial design and assembly / Michael J Smanski and others
13the draft genome sequence of the ferret (Mustela putorius furo) facilitates study of human respiratory disease / Xinxia Peng and others
14efficient delivery of rNAi prodrugs containing reversible charge-neutralizing phosphotriester backbone modifications / Bryan R Meade and others
15rational design of highly active sgrNAs for CrIsPr-Cas9–mediated gene inactivation / John G Doench and others
16A load driver device for engineering modularity in biological networks / Deepak Mishra and others
17tunable protein degradation in bacteria / D Ewen Cameron, James J Collins
18The business case for cell and gene therapies